Author:
Biermasz Nienke R.,Pereira Alberto M.,Smit Jan W.A.,Romijn Johannes A.,Roelfsema Ferdinand
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference35 articles.
1. Primary medical therapy for acromegaly: an open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor size;Bevan;J Clin Endocrinol Metab,2002
2. Primary medical therapy for acromegaly;Sheppard;Clin Endocrinol (Oxf),2003
3. Efficacy of Sandostatin LAR (long-acting somatostatin analogue) is similar in patients with untreated acromegaly and in those previously treated with surgery and/or radiotherapy;Ayuk;Clin Endocrinol (Oxf),2004
4. The treatment of de novo acromegalic patients with octreotide-LAR: efficacy, tolerability and cardiovascular effects;Gilbert;Pituitary,2003
5. Somatostatin analogs in acromegaly;Freda;J Clin Endocrinol Metab,2002
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献